Trial Details

Not Recruiting
Basic Information
Clinical ID c3377
Identifier EUCTR2005-000496-17-SE
Trial Title Atorvastatin in moderat active Crohns disease
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Crohn's disease is an idiopathic chronic inflammatory bowel disease thought to result from inappropriate and ongoing activation of the mucosal immune system driven by the presence of normal luminal flora. It may affect the hole gastrointestinal tract, from mouth to rectum, with symptoms such as diarrhea, weight lose, malabsorption, abdominal pain and fever.
Interventions Product Name: atorvastatin Pharmaceutical Form: Tablet
Participant Information
Sponsor Region Skåne
City -
Country/Region Sweden
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -